Akari Therapeutics - 53 Year Dividend History | AKTX
Historical dividend payout and yield for Akari Therapeutics (AKTX) since 1971. The current TTM dividend payout for Akari Therapeutics (AKTX) as of November 01, 2024 is $0.00. The current dividend yield for Akari Therapeutics as of November 01, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.034B |
$0.000B |
|
Akari Therapeutics PLC is a biopharmaceutical company. It focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The Company's lead drug consist of Coversin is a recombinant small protein, which acts on complement component-C5, preventing release of C5a and formation of C5b-9. Akari Therapeutics PLC, formerly known as Celsus Therapeutics Plc, is based in London, United Kingdom.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
